mdl-201112 has been researched along with cyclosporine in 2 studies
| Studies (mdl-201112) | Trials (mdl-201112) | Recent Studies (post-2010) (mdl-201112) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 30,547 | 3,802 | 6,558 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bluethmann, H; Bonventre, PF; Cullen, CM; Edwards, CK; Heeg, H; Mountz, JD | 1 |
| Benda, B; Holstad, M; Korsgren, O; Lycke, N | 1 |
2 other study(ies) available for mdl-201112 and cyclosporine
| Article | Year |
|---|---|
A fas antigen receptor mutation allows development of toxic shock syndrome toxin-1-induced lethal shock in V beta 8.2 T-cell receptor transgenic mice.
Topics: Adenine; Animals; Bacterial Toxins; Base Sequence; Cells, Cultured; Cyclosporine; Enterotoxins; fas Receptor; Female; Heterozygote; Interleukin-2; Interleukin-6; Isoquinolines; Lipopolysaccharides; Liver; Lymphocyte Activation; Mice; Mice, Transgenic; Molecular Sequence Data; Mutation; Nitrogen Oxides; Receptors, Antigen, T-Cell, alpha-beta; Recombinant Proteins; Shock, Septic; Spleen; Superantigens; Tumor Necrosis Factor-alpha | 1995 |
Delayed type hypersensitivity-associated cytokines in islet xenotransplantation: limited efficacy of interleukin-2- and tumor necrosis factor-alpha-blockade in interferon-gamma receptor-deficient mice.
Topics: Adenine; Animals; Cyclosporine; Cytokines; Female; Fetal Tissue Transplantation; Graft Rejection; Hypersensitivity, Delayed; Immunosuppressive Agents; Interferon gamma Receptor; Interleukin-2; Islets of Langerhans Transplantation; Lymphocytes; Mice; Mice, Inbred Strains; Mice, Knockout; Receptors, Interferon; Swine; Transplantation, Heterologous; Tumor Necrosis Factor-alpha | 2000 |